Showing results (131-140 of 154) with videos related to
Sort By:
Pageof 16
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 29, 2025
Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disordersPaolo Abondio, Giuseppe Fanelli, Valentina Baldini, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 29, 2021
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant responseGiuseppe Fanelli, Katharina Domschke, Alessandra Minelli, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 23, 2025
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysisVincenzo Oliva, Chiara Possidente, Giuseppe Fanelli, et al.Journal of Alzheimer'S Disease : JAD|January 23, 2009
Lack of association between interleukin-1 alpha rs1800587 polymorphism and Alzheimer's disease in two Independent European samplesAlessandro Serretti, Paolo Olgiati, Antonis Politis, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 29, 2013
Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samplesStefano Porcelli, Raffaele Salfi, Antonis Politis, et al.Neuroscience Letters|January 17, 2020
Genetic variants associated with psychotic symptoms across psychiatric disordersMarco Calabrò, Stefano Porcelli, Concetta Crisafulli, et al.Neuroscience Applied|July 14, 2025
Polygenic scores of subcortical brain volumes as possible modulators of treatment response in depressionVincenzo Oliva, Alfonso Martone, Giuseppe Fanelli, et al.Neurobiology of Aging|February 5, 2013
Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitorsFilippo Martinelli-Boneschi, Giacomo Giacalone, Giuseppe Magnani, et al.Journal of Alzheimer'S Disease : JAD|January 26, 2011
An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's diseaseFrancesco Lescai, Andrea Maria Chiamenti, Alessandra Codemo, et al.Journal of Alzheimer'S Disease : JAD|June 20, 2018
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain BiomarkersMoira Marizzoni, Clarissa Ferrari, Jorge Jovicich, et al.Pageof 16